Advertisement

Pathogenesis of Plasmacytomas in Mice

  • Michael Potter
Chapter
Part of the Cancer, A Comprehensive Treatise book series (C)

Abstract

The malignant plasmacytoma is a rare tumor type that occurs naturally in several mammals—the dog (Osborne et al., 1968), the cat (Farrow and Penny, 1971), the hamster (Cotran and Fortner, 1962), the rat (Bazin et al., 1972), the mouse (Dunn, 1954, 1957), and man (Azar, 1973). Because plasmacytomas occur infrequently, it is difficult to study their pathogenesis. It is possible, however, to induce plasmacytomas in high frequency in a few uniquely susceptible inbred strains of mice by the intraperitoneal implantation of solid plastic materials (Merwin and Algire, 1959; Merwin and Redmon, 1963) or the intraperitoneal injection of mineral oils and related substances (Potter and Robertson, 1960; Potter and Boyce, 1962; Anderson and Potter, 1969). While this unusual method of induction is a laboratory method and has no apparent relationship to any known natural form of plasmacytoma development, it provides a means for studying the pathogenesis of plasmacytomas. In many forms of carcinogenesis, a specific differentiated cell type is the selective target. The reasons for cytotropism in the carcinogenic process are an intriguing problem. In plasma cell tumor formation in mice, the problem is even more complex because a segment of the plasma cell population appears particularly vulnerable. At present, immunology is an area of biology that has captured broad interest, and from many investigations have come a wealth of data on the differentiation, development, physiology, and proliferation of plasma cells. These data provide the background for understanding the normal plasma cell and the process of plasmacytoma formation. In this chapter, the pathogenesis of the induction of peritoneal plasmacytomas will be the main topic. The underlying mechanisms of peritoneal plasmacytoma formation in the mouse are not yet established, but it is hoped that insight gained from this study will provide a basis for understanding how plasmacytomas may develop “spontaneously” in the mouse and in other species, including man.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, S. A., and Stephenson, J. R., 1973, Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells, Proc. Natl. Acad. Sci. USA 70: 2055–2058.PubMedGoogle Scholar
  2. Aaronson, S. A., Hartley, J. W., and Todaro, G. J., 1969, Mouse leukemia virus “spontaneous” release by mouse embryo cells after long term in vitro cultivation, Proc. Natl. Acad. Sci. USA 64: 87.PubMedGoogle Scholar
  3. Abelson, H. T., and Rabstein, L. S., 1970a, Influence of prednisolone on Moloney leukemogenic virus in Balb/c mice, Cancer Res. 30: 2208–2212.PubMedGoogle Scholar
  4. Abelson, H. T., and Rabstein, L. S., 1970b, Lymphosarcoma: Virus-induced thymic-independent disease in mice, Cancer Res. 30: 2213–2222.Google Scholar
  5. Anderson, P. N., 1970, Plasma cell tumor induction in Balb/c mice, Proc. Am. Assoc. Cancer Res. 11: 3 (abstract).Google Scholar
  6. Anderson, P. N., and Potter, M., 1969, Induction of plasma cell tumors in Balb/c mice with 2,6,10,14-tetramethylpentadecane (pristane), Nature (London) 222: 994–995.Google Scholar
  7. Aoki, T., and Takahashi, T. L., 1972, Viral and cellular surface antigens of murine leukemias and myelomas, J. Exp. Med. 135: 443–457.Google Scholar
  8. Aoki, T., Potter, M., and Sturm, M. M., 1973, Analysis by immunoelectron microscopy of type-C viruses associated with primary and short-term transplanted mouse plasma (H) tumors, J. Natl. Cancer Inst. 51: 1609–1617.PubMedGoogle Scholar
  9. Armstrong, M. Y. K., Ebenstein, P., Konigsberg, W. H., and Richards, F. F., 1978, Endogenous Rna tumor viruses are activated during chemical induction of murine plasmacytomas, Proc. Natl. Acad. Sci. USA 75: 4549–4552.PubMedGoogle Scholar
  10. Azar, H. A., 1973, Pathology of multiple myeloma and related growths, in: Multiple Myeloma and Related Disorders ( H. A. Azar and M. Potter, eds.), pp. 1–85, Harper and Row, New York.Google Scholar
  11. Baltimore, D., Rosenberg, N., and Witte, O. N., 1979, Transformation of immature lymphoid cells by Abelson murine leukemia virus, Immunof Rev. 48: 3–22.Google Scholar
  12. Bazin, H., Deckers, C., Beckers, A., and Heremans, J. F., 1972, Transplantable immunoglobulin secreting tumours in rats. I. General features of Lou/Wsl strain rat immunocytomas and their monoclonal proteins, Int. J. Cancer 10: 568–580.PubMedGoogle Scholar
  13. Bazin, H., Beckers, A., Deckers, C., and Moriame, M., 1973, Transplantable immunoglobulinsecreting tumors in rats. V. Monoclonal immunoglobulins secreted by 250 ileocecal immunocytomas in Lou/Wsl rats, J. Natl. Cancer Inst. 51: 1359–1362.PubMedGoogle Scholar
  14. Bendoraitis, J. G., Brown, B. L., and Hepner, L. S., 1962, Isoprenoid hydrocarbons in petroleum isolation of 2,6,10,14-tetramethylpentadecane by high temperature gas—liquid chromatography, Anal. Chem. 34: 49–53.Google Scholar
  15. Blumer, M., 1965, “Zamene,” isomeric C19 mono-olefins from marine zooplankton, fishes, and mammals, Science 148:370–371.Google Scholar
  16. Blumer, M., and Thomas, D., 1965, Phytadienes in zooplankton, Science 147: 1148–1149.PubMedGoogle Scholar
  17. Blumer, M., Mullin, M. M., and Thomas, D. W., 1963, Pristane in zooplankton, Science 140: 974.PubMedGoogle Scholar
  18. Blumer, M., Robertson, J. C., Gordon, J. E., and Sass, J., 1969, Phytol derived C19 di- and triolefinic hydrocarbons in marine zooplankton and fishes, Biochemistry 8: 4067–4074.PubMedGoogle Scholar
  19. Cancro, M., and Potter, M., 1976, The requirement of an adherent substratum for the growth of developing plasmactyoma cells in viva, J. Exp. Med. 144: 1554–1566.Google Scholar
  20. Carr, I., 1967, The fine structure of cells of the mouse peritoneum, Z. Zellforsch. Mikrosk. Anat. 80: 534–555.PubMedGoogle Scholar
  21. Collett, M. S., Erikson, E., Purchio, A. F., Brugge, J. S., and Erikson, R. L., 1979, A normal cell protein similar in structure and function to the avian sarcoma virus transforming gene product, Proc. Natl. Acad. Sci. USA 76: 3159–3163.PubMedGoogle Scholar
  22. Comoglio, P. M., and Guglielmone, R., 1973, Immunohistochemical study of IgA transepithelial transfer into digestive tract secretions in the mouse, Immunology 25: 71–80.PubMedGoogle Scholar
  23. Cotran, R. S., and Fortner, J. B., 1962, Serum protein abnormality in a transplantable plasmacytoma of the Syrian hamster, J. Natl. Cancer Inst. 28: 1193–1205.PubMedGoogle Scholar
  24. CrabbÉ, P. A., Nash, D. R., Baxin, H., Eyssen, H., and Heremans, J. F., 1970, Immunochemical observations on lymphoid tissues from conventional and germ free mice, Lab. Invest. 22: 448–457.PubMedGoogle Scholar
  25. Dalton, A. J., and Potter, M., 1968, Electronmicroscope study of the mammary tumor agent in plasma cell tumors, J. Natl. Cancer Inst. 40: 1375–1385.PubMedGoogle Scholar
  26. Dalton, A. J., Potter, M., and Merwin, R. M., 1961, Some ultrastructural characteristics of a series of primary and transplanted plasma cell tumors of the mouse, J. Natl. Cancer Inst. 26: 1221–1267.PubMedGoogle Scholar
  27. Deckers, C., 1963, Etude electrophoretique et immunoelectrophoretique des proteines du rat atteint de leucosarcome, Protides Biol. Fluids Proc. Colloq. 11: 105–108.Google Scholar
  28. Dunn, T. B., 1954, Normal and pathologic anatomy of the reticular tissue in laboratory mice with a classification and discussion of neoplasms, J. Natl. Cancer Inst. 14: 1281–1433.PubMedGoogle Scholar
  29. Dunn, T. B., 1957, Plasma-cell neoplasms beginning in the ileocecal area in strain C3H mice, J. Natl. Cancer Inst. 19: 371–391.PubMedGoogle Scholar
  30. Dunn, T. B., and Deringer, M. K., 1968, Reticulum cell neoplasm, type B or the “Hodgkin’s-like lesion” of the mouse, J. Natl. Cancer Inst. 40: 771–821.PubMedGoogle Scholar
  31. Dunn, T. B., Moloney, J. B., Green, A. W., and Arnold, B., 1961, Pathogenesis of a virus induced leukemia in mice, J. Natl. Cancer Inst. 26: 189–221.PubMedGoogle Scholar
  32. Ebbesen, P., Rasknielsen, R., and Mcintire, K. R., 1968, Plasmacell leukemia in Balb/c mice inoculated with subcellular material. I. Incidence and morphology, J. Natl. Cancer Inst. 41: 473–493.PubMedGoogle Scholar
  33. Fahey, J. L., Potter, M., Gutter, F. J., and Dunn, T. B., 1960, Distinctive myeloma globulins associated with a new plasma cell neoplasm of strain C3H mice, Blood 15: 103–113.PubMedGoogle Scholar
  34. Farrow, B. R. H., and Penny, R., 1971, Multiple myeloma in a cat, J. Am. Vet. Med. Assoc. 158: 606–611.Google Scholar
  35. Gearhart, P. J., and Cebra, J. J., 1979, Differentiated B-lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load, J. Exp. Med. 149: 216–227.PubMedGoogle Scholar
  36. Gearhart, P. J., Hurwitz, J. L., and Cebra, J. J., 1980, Successive switching of antibody isotypes expressed within the lines of a cell clone, Proc. Natl. Acad. Sci. USA 77: 5424–5428.PubMedGoogle Scholar
  37. Gibson, D. M., Taylor, B. A., and Cherry, M., 1978, Evidence for close linkage of a mouse light chain marker with the Ly 2.3 locus, J. Immunol. 121: 1585.PubMedGoogle Scholar
  38. Goldstein, G. L., Warner, N. L., and Holmes, M. C., 1966, Plasma cell tumor induction in (Nzb x Balb/c)f 1 hybrid mice, J. Natl. Cancer Inst. 37: 135–143.PubMedGoogle Scholar
  39. Graft, T., Brug, H., and Hayman, M. J., 1980, Target cell specificity of defective avian leukemia viruses: Hematopoietic target cells for a given virus type can be infected but not transformed by strains of a different type, Proc. Natl. Acad. Sci. USA 77: 389–393.Google Scholar
  40. Hengartner, H., Meo, T., and Muller, E., 1978, Assignment of genes for immunoglobulin K and heavy chains to chromosomes 6 and 12 in mouse, Proc. Natl. Acad. Sci. USA 75: 4494–4498.PubMedGoogle Scholar
  41. Herberman, R. B., and Aoki, T., 1972, Immune and natural antibodies to syngeneic murine plasma cell tumors, J. Exp. Med. 136: 94–111.PubMedCentralPubMedGoogle Scholar
  42. Hersey, P., and Maclennan, I. C. M., 1973, Macrophage dependent protection of tumor cells, Immunology 24: 385–393.PubMedGoogle Scholar
  43. Hollander, W. P., Takakura, K., and Yamada, H., 1968, Endocrine factors in the pathogenesis of plasma cell tumors, Recent Prog. Horm. Res. 24: 81–137.Google Scholar
  44. HoNjo, T., and Kataoka, T., 1978, Organization of immunoglobulin heavy chain genes and allelic deletion model, Proc. Natl. Acad. Sci. USA 75: 2140–2144.Google Scholar
  45. Hyman, R., Ralph, P., and Sarkar, S., 1972, Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants, J. Natl. Cancer Inst. 48: 173–184.PubMedGoogle Scholar
  46. Klein, G., 1979, Lymphoma development in mice and men: Diversity of initiation is followed by a convergent cytogenetic evolution, Proc. Natl. Acad. Sci. USA 76: 2442–2446.PubMedGoogle Scholar
  47. Koster, F. T., and Mcgregor, D. C., 1971, The mediator of cellular immunity Iii Lymphocyte traffic from the blood into the inflamed peritoneal cavity, J. Exp. Med. 133: 864–876.PubMedCentralPubMedGoogle Scholar
  48. Kripke, M. L., and Weiss, D. W., 1970, Studies on the immune responses of Balb/c mice during tumor induction by mineral oil, Int. J. Cancer 6: 422–430.PubMedGoogle Scholar
  49. Kuff, E. L., Wivel, N. A., and Lueders, K. R., 1968, The extraction of intracisternal A particles from a mouse plasma cell tumor, Cancer Res. 28: 2137–2148.PubMedGoogle Scholar
  50. Kuff, E. L., Lueders, K. K., Ozer, H. L., and Wivel, N. A., 1972, Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors, Proc. Natl. Acad. Sci. USA 69: 218.Google Scholar
  51. Lespinats, G., 1969, Induction d’une immunite vis-à-vis de la greffe de plasmacytosarcomes chez la souris Balb/c, Eur. J. Cancer 5: 421–426.PubMedGoogle Scholar
  52. Levy, J. A., and Pincus, T., 1970, Demonstration of biological activity of a murine leukemia virus of New Zealand black mice, Science 170: 326–327.PubMedGoogle Scholar
  53. Lieberman, R., Douglas, J. O., and Mantel, N., 1960, Production in mice of ascitic fluid containing antibodies induced by Staphylococcus— or Salmonella—adjuvant mixtures, J. Immunol. 84: 514–529.PubMedGoogle Scholar
  54. Lynch, R. G., Graff, R. J., Sirisinha, S., Simms, E. S., and Eisen, H. N., 1972, Myeloma proteins as tumor-specific transplantation antigens, Proc. Natl. Acad. Sci. USA 69: 1540–1544.PubMedGoogle Scholar
  55. Mcintire, K. R., and Princler, G. L., 1969, Prolonged adjuvant stimulation in germ-free Balb/c mice: Development of plasma cell neoplasia, Immunology 17: 481–487.PubMedGoogle Scholar
  56. Meo, T., Johnson, J., Beechey, C. V., Andrews, S. J., Peters, J., and Searle, A. G., 1980, Linkage analysis of murine immunoglobulin heavy chain and serum prealbumin genes establish their location on chromosome 12 proximal to the T(5;12)3H breakpoint in band 12F1, Proc. Natl. Acad. Sci. USA 77: 550–553.PubMedGoogle Scholar
  57. Merwin, R. M., and Algire, G. H., 1959, Induction of plasma cell neoplasms and fibrosarcomas in Balb/c mice carrying diffusion chambers, Proc. Soc. Exp. Biol. Med. 101: 437–439.PubMedGoogle Scholar
  58. Merwin, R. M., and Redmon, L. W., 1963, Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity, J. Natl. Cancer Inst. 31: 998–1007.Google Scholar
  59. Metcalf, D., 1973, Colony formation in agar by murine plasmacytoma cells: Potentiation by hematopoietic cells and serum, J. Cell. Physiol. 81: 397–410.PubMedGoogle Scholar
  60. Moloney, J. B., 1962, The murine leukemias, Fed. Proc. 21: 19–31.PubMedGoogle Scholar
  61. Moriwaki, K., Imai, H. T., Yamashita, J., and Yosida, T. H., 1971, Ploidy fluctuations of mouse plasma cell neoplasm MsPC-1 during serial transplantation, J. Natl. Cancer Inst. 46: 623–637.Google Scholar
  62. Morse, H. C., Riblet, R., Asofsky, R., and Weigert, M., 1978, Plasmacytomas of the Nzb mouse, J. Immunol. 121: 1969–1972.PubMedGoogle Scholar
  63. Morse, H. C., Hartley, J. W., and Potter, M., 1980, Genetic considerations in plasmacytomas of Balb/c, Nzb and (Balb/c x Nzb)F1 mice, in: Progress in Myeloma, 1980 ( M. Potter, ed.), Elsevier/North-Holland, New York.Google Scholar
  64. Namba, Y., and Hanaoka, M., 1972, Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture, J. Immunol. 109: 1193–1200.PubMedGoogle Scholar
  65. Nesbitt, M. N., and Franke, U., 1973, A system of nomenclature for band patterns of mouse chromosomes, Chromosoma 41: 145–148.PubMedGoogle Scholar
  66. Ohno, S., Babonits, M., Wiener, F., Spira, J., Klein, G., and Potter, M., 197, Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in Pristane-induced mouse plasmacytomas, Cell 18: 1001–1007.Google Scholar
  67. Oppenheimer, B. S., Oppenheimer, E. T., Danishetsky, I., Stout, A. P., and Elrich, F. R., 1955, Further studies of polymers as carcinogenic agents in animals, Cancer Res. 15: 333–340.PubMedGoogle Scholar
  68. Osborne, C. A., Perman, V., Sautter, J. H., Stevens, J. B., and Hanlon, G. F., 1968, Multiple myeloma in the dog, J. Am. Vet. Med. Assoc. 153: 1300–1319.Google Scholar
  69. Park, C. H., Bergsagel, D. E., and Mcculloch, E. A., 1971, Mouse myeloma tumor stem cells: A primary culture assay, J. Natl. Cancer Inst. 46: 411–422.PubMedGoogle Scholar
  70. Peters, R. L., Rabstein, L. S., Spahn, G. J., Madison, R. M., and Huebner, R. J., 1972a, Incidence of spontaneous neoplasms in breeding and retired breeder Balb/c Cr mice throughout the natural life span, Int. J. Cancer 10: 273–282.PubMedGoogle Scholar
  71. Peters, R. L., Hartley, J. W., Spahn, G. J., Rabstein, L. S., Whitmore, L. S., Turner, H. C., and Huebner, R. J., 1972 b, Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type Rna viruses during the life span of Balb/c Cr mice, Int. J Cancer 10: 283–289.Google Scholar
  72. Peters, R. L., Rabstein, L. S., Spahn, G. J., Turner, H. C., and Huebner, R. J., 1972c, Incidence of group-specific (gs) antigens of type C Rna tumor viruses in spontaneous neoplasms of Balb/c Cr mice, Int. J. Cancer 10: 290–295.PubMedGoogle Scholar
  73. Pilgrim, H. I., 1965, The relationship of chronic ulceration of the ileocecal junction to the development of reticuloendothelial tumors in C3H mice, Cancer Res. 25: 53–65.PubMedGoogle Scholar
  74. Potter, M., 1967, The plasma cell tumors and myeloma proteins of mice, in: Methods in Cancer Research, Vol. II ( H. Busch, ed.), pp. 105–157, Academic Press, New York.Google Scholar
  75. Potter, M., 1970, Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin, Fed. Proc. 29: 85–91.PubMedGoogle Scholar
  76. Potter, M., 1971, Antigen binding myeloma proteins in mice, Ann. N. Y. Acad. Sci. 190: 306–321.PubMedGoogle Scholar
  77. Potter, M., 1972, Immunoglobulin producing tumors and myeloma proteins in mice, Physiol. Rev. 52: 631–719.PubMedGoogle Scholar
  78. Potter, M., and Boyce, C., 1962, Induction of plasma cell neoplasms in strain Balb/c mice with mineral oil and mineral oil adjuvants, Nature (London) 193: 1086–1087.Google Scholar
  79. Potter, M., and Fahey, J. L., 1960, Studies on eight transplantable plasma cell neoplasms in mice, J. Natl. Cancer Inst. 24: 1153–1165.PubMedGoogle Scholar
  80. Potter, M., and Maccardle, R. C., 1964, Histology of developing plasma cell neoplasia induced by mineral oil in Balb/c mice, J. Natl. Cancer Inst. 33: 497–515.PubMedGoogle Scholar
  81. Potter, M., and Robertson, C. L., 1960, Development of plasma cell neoplasms in Balb/c mice after intraperitoneal injection of paraffin oil adjuvant—heat killed staphylococcus mixtures, J. Natl. Cancer Inst. 25: 847–861.PubMedGoogle Scholar
  82. Potter, M., and Walters, J. L., 1973, Effects of intraperitoneal pristane on established immunity to the Adj-PC-5 plasmacytoma, J. Natl. Cancer Inst. 51: 875–881.PubMedGoogle Scholar
  83. Potter, M., Fahey, J. L., and Pilgrim, H. I., 1957, Abnormal serum protein and bone destruction in transmissible mouse plasma cell neoplasm (multiple myeloma), Proc. Soc. Exp. Biol. Med. 94: 327–333.PubMedGoogle Scholar
  84. Potter, M., Pumphrey, J. G., and Walters, J. L., 1972, Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment, J. Natl. Cancer Inst. 49: 305–308.PubMedGoogle Scholar
  85. Potter, M., Sklar, M. D., and Rowe, W. P., 1973, Rapid viral induction of plasmacytomas in pristane primed Balb/c mice, Science 182: 592–594.PubMedGoogle Scholar
  86. Potter, M., Pumphrey, J. G., and Bailey, D. W., 1975, Genetics of susceptibility of plasmacytoma induction. I. Balb/cAnN(C), C57BL/6N(B6) C57BL/Ka(BK), (C x B6)F1, (C x BK)F1 and C x B recombinant inbred strains, J. Natl. Cancer Inst. 54: 1413–1417.PubMedGoogle Scholar
  87. Potter, M., Premkumarreddy, E., and Wivel, N. A., 1978, Immunoglobulin production by lymphosarcomas induced by Abelson virus in mice, in: Gene Expression and Regulation in Cultured Cells (K. K. Sanford, ed.), pp. 311–320, Nci Monograph 48.Google Scholar
  88. Premkumar, E., Potter, M., Singer, P. A., and Sklar, M. D., 1975, Synthesis, surface deposition and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines, Cell 6: 149–159.PubMedGoogle Scholar
  89. Rask-Nielsen, R., Mcintire, K. R., and Ebbesen, P., 1968, Plasma-cell leukemia in Balb/c mice inoculated with subcellular material Serological changes, J. Natl. Cancer Inst. 41: 495–504.Google Scholar
  90. Risser, R., Stockert, E., and Old, L. J., 1978, Abelson antigen: A new viral tumor antigen that is also a differentiation antigen Balb/c, Proc. Natl. Acad. Sci. U.S.A. 75: 3918–3922.PubMedCentralPubMedGoogle Scholar
  91. Rollinghoff, M., Rouse, B. T., and Warner, N. L., 1973, Tumor immunity to murine plasma cell tumors Tumor-associated transplantation antigens of Nzb and Balb/c plasma cell tumors, J. Natl. Cancer Inst. 50: 159–172.PubMedGoogle Scholar
  92. Rosenberg, N., and Baltimore, D., 1976, A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus, J. Exp. Med. 143: 1453–1463.PubMedGoogle Scholar
  93. Rosenberg, N., Baltimore, D., and Scher, C. D., 1975, In vitro transformation of lymphoid cell by Abelson murine leukemia virus, Proc. Natl. Acad. Sci. USA 72: 1932–1936.Google Scholar
  94. Shepard, J. S., Pettengill, O. S., Wurster-Hill, D. H., and Sorenson, G. D., 1974a, Alterations of karyotype and oncogenicity in mouse myeloma Mopc315 and 5-bromodeoxyuridine-resistant cell line, Cancer Res. 34: 2852–2858.Google Scholar
  95. Shepard, J. S., Wurster-Hill, D. H., Pettengill, O. S., and Sorenson, G. D., 1974b, Giemsa banded chromosomes of mouse myeloma in relationship to oncogenicity, Cytogenet. Cell Genet. 13: 279–304.Google Scholar
  96. Shepard, J. S., Pettengill, O. S., Wurster-Hill, D. H., and Sorenson, G. D., 1976, Karyotype marker formation and oncogenicity in mouse plasmacytomas, J. Natl. Cancer Inst. 56: 1003–1011.Google Scholar
  97. Shepard, J. S., Pettengill, O. S., Wurster-Hill, D. H., and Sorenson, G. D., 1978, A specific chromosome breakpoint associated with mouse plasmacytomas, J. Natl. Cancer Inst. 61: 225–258.Google Scholar
  98. Siden, E. J., Baltimore, D., Clark, D., and Rosenberg, N. E., 1979, Immunoglobulin synthesis by lymphoid cells transformed by in vitro Abelson murine leukemia virus, Cell 5: 389–396.Google Scholar
  99. Stockert, E., Old, L. J., and Boyse, E. A., 1971, The G,,, system: A cell surface antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome, J. Exp. Med. 133: 1334–1355.PubMedCentralPubMedGoogle Scholar
  100. Swan, D., E’Eustachio, P., Leinwand, L., Seidman, J., Keithley, D., and Ruddle, F. H., 1979, Chromosomal assignment for the mouse K light chain genes, Proc. Natl. Acad. Sci. USA 76: 27352739.Google Scholar
  101. Takahashi, T., Old, L. J., and Boyse, E. A., 1970, Surface alloantigens of plasma cells, J. Exp. Med. 131: 1325–1341.PubMedCentralPubMedGoogle Scholar
  102. Takahashi, T., Old, L. J., Hsu, C. J., and Boyse, E. A., 1971a, A new differentiation antigen of plasma cells, Eur. J. Immunol. 1: 478.PubMedGoogle Scholar
  103. Takahashi, T., Old, L. J., Mcintire, K. R., and Boyse, E. A., 1971 b, Immunoglobulin and other surface antigens of cells of the immune system, J. Exp. Med. 134: 815–832.Google Scholar
  104. Takakura, K., Mason, W. B., and Hollander, W. P., 1966, Studies on the pathogenesis of plasma cell tumors. I. Effect of cortisone on development of plasma cell tumors, Cancer Res. 26: 596–599.PubMedGoogle Scholar
  105. Thompson, J., and Vanfurth, R., 1970, The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes, J. Exp. Med. 131: 429–442.PubMedCentralPubMedGoogle Scholar
  106. Tomasi, T. B., JR., and Bienenstock, J., 1968, Secretory immunoglobulins, Adv. Immunol. 9: 1–96.PubMedGoogle Scholar
  107. Van Duuren, B. L., Nelson, N., Orris, L., Palmes, E. D., and Schmitt, F. L., 1963, Carcinogenicity of epoxides, lactones, and peroxy compounds, J. Natl. Cancer Inst. 31: 41–55.Google Scholar
  108. Van Duuren, B. L., Langseth, L., Goldschmidt, B. M., and Orris, L., 1967, Carcinogenicity of epoxides, lactones and peroxy compounds. VI. Structure and carcinogenic activity, J. Natl. Cancer Inst. 39: 1217–1228.PubMedGoogle Scholar
  109. Volkman, A., 1966, The origin and turnover of mononuclear cells in peritoneal exudates in rats, J. Exp. Med. 124: 241–253.PubMedCentralPubMedGoogle Scholar
  110. Volkman, L. E., and Krueger, R. G., 1973, XC cell cytopathogenicity as an assay for murine myeloma C-type virus, J. Natl. Cancer Inst. 51: 1205–1210.PubMedGoogle Scholar
  111. Warner, N. L., 1975, Review. Autoimmunity and the pathogenesis of plasma cell tumor induction in Nzb and hybrid mice, Immunogenetics 2: 1–20.Google Scholar
  112. Watson, J., Ralph, P., and Sarkar, S., 1970, Leukemia viruses associated with mouse myeloma cells, Proc. Natl. Acad. Sci. USA 66: 344–351.PubMedGoogle Scholar
  113. Williams, W. H., and Krueger, R. G., 1972, Tumor-associated transplantation antigens of myelomas induced in Balb/c mice, J. Natl. Cancer Inst. 49: 1613–1620.PubMedGoogle Scholar
  114. Wilson, S. H., and Kuff, E. L., 1972, A novel Dna polymerase activity found in association with intracisternal-A particles, Proc. Natl. Acad. Sci. USA 69: 1531–1536.PubMedGoogle Scholar
  115. Witte, O. N., Rosenberg, N. E., and Baltimore, D., 1979, Normal cell protein cross-reaction to the major Abelson murine leukemia virus gene product, Nature (London) 281: 396–398.Google Scholar
  116. Wivel, N. A., and Smith, G. H., 1971, Distribution of intracisternal A particles in a variety of normal and neoplastic mouse tissues, Int. J. Cancer 7: 167–175.PubMedGoogle Scholar
  117. Yamada, H., Mashburn, L. T., Takakura, K., and Hollander, W. P., 1969, The correlation between plasma cell tumor development and antibody response in inbred strains of mice, Proc. Soc. Exp. BioL Med. 131: 947–950.PubMedGoogle Scholar
  118. Yancey, S. T., 1964, Plasma cell neoplasm arising in a Caf1 mouse: Characteristics and response to certain chemotherapeutic agents, J. Natl. Cancer Inst. 33: 373–382.PubMedGoogle Scholar
  119. Yosida, M. C., and Moriwaki, K., 1975, Specific marker chromosomes involving a translocation (12;15) in a mouse myeloma, Proc. Jpn. Acad. 51: 588–592.Google Scholar
  120. Yosida, M. C., Moriwaki, K., and Migita, S., 1978, Specificity of the deletion of chromosome No. 15 in mouse plasmacytoma, J. Natl. Cancer Inst. 60: 235–238.Google Scholar
  121. Yosida, T. H., Imac, H. T., and Potter, M., 1968, Chromosomal alteration and development of tumors. Xix. Chromosome constitution of tumor cells in 16 plasma cell neoplasms of Balb/c mice, J. Natl. Cancer Inst. 41: 1083–1087.PubMedGoogle Scholar
  122. Yosida, T. H., Imai, H. T., and Moriwaki, K., 1970, Chromosomal alteration and development of tumors. Xxi. Cytogenetic studies of primary plasma cell neoplasms induced in Balb/c mice, J. Natl. Cancer Inst 45: 411–418.PubMedGoogle Scholar
  123. Zawadzki, Z. A., Edwards, G. A., and Adams, R. V., 1967, M-components in immunoproliferative disorders. Electrophoretic and immunological analysis of 200 cases, Am. J. Clin. Pathol. 48: 418–430PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Michael Potter
    • 1
  1. 1.Laboratory of Cell BiologyNational Cancer InstituteBethesdaUSA

Personalised recommendations